Drug Profile
SPV 30
Latest Information Update: 15 Mar 2007
Price :
$50
*
At a glance
- Originator Arkopharma
- Developer Arkopharma; Unknown
- Class Phytotherapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chronic fatigue syndrome; HIV infections